What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Conduct a value analysis of cash back cards with no fees to make smart financial choices. Understand the benefits and options available.
25,276 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Tesla reports a robust quarter with deliveries around 515,000, topping expectations and reigniting investor optimism....
Apple stock has turned heads for years with strong profitability and a steady drip of shareholder rewards. This artic...
A major institution disclosed a sizable stake in the Akre Focus ETF, signaling strong conviction in a concentrated gr...
On a day shaped by geopolitical optimism, the stock market today showed modest gains as investors priced in the poten...
Nautilus' early 2026 results could signal demand for home fitness gear and pricing power. This analysis breaks down t...
Before you lend or invest, you need a clear view of the market. This guide covers four practical metrics to analyze a...
As 2025 unfolds, sight sciences (sght) 2025 becomes a focal point for ophthalmology investors. This guide breaks down...
Could the SanDisk brand—now part of Western Digital—spark a trillion-dollar valuation in five years? This article bre...
When Netflix reportedly missed out on Roku, investors asked: what does this mean for the company’s future profits and...
When a downgrade hits a stock, it can spark more questions than answers. This article unpacks why phreesia stock cloc...
Alphabet shifted gears, stepping away from a $346B AI bet to chase faster AI-driven wins. Here’s what that means for ...